382 related articles for article (PubMed ID: 37253117)
1. NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis.
Potere N; Garrad E; Kanthi Y; Di Nisio M; Kaplanski G; Bonaventura A; Connors JM; De Caterina R; Abbate A
Cardiovasc Res; 2023 Sep; 119(11):2046-2060. PubMed ID: 37253117
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications.
Potere N; Del Buono MG; Caricchio R; Cremer PC; Vecchié A; Porreca E; Dalla Gasperina D; Dentali F; Abbate A; Bonaventura A
EBioMedicine; 2022 Nov; 85():104299. PubMed ID: 36209522
[TBL] [Abstract][Full Text] [Related]
3. NLRP3, the inflammasome and COVID-19 infection.
Yin M; Marrone L; Peace CG; O'Neill LAJ
QJM; 2023 Jul; 116(7):502-507. PubMed ID: 36661317
[TBL] [Abstract][Full Text] [Related]
4. Targeting the NLRP3 inflammasome in cardiovascular diseases.
Toldo S; Mezzaroma E; Buckley LF; Potere N; Di Nisio M; Biondi-Zoccai G; Van Tassell BW; Abbate A
Pharmacol Ther; 2022 Aug; 236():108053. PubMed ID: 34906598
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Gaul S; Leszczynska A; Alegre F; Kaufmann B; Johnson CD; Adams LA; Wree A; Damm G; Seehofer D; Calvente CJ; Povero D; Kisseleva T; Eguchi A; McGeough MD; Hoffman HM; Pelegrin P; Laufs U; Feldstein AE
J Hepatol; 2021 Jan; 74(1):156-167. PubMed ID: 32763266
[TBL] [Abstract][Full Text] [Related]
7. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
[TBL] [Abstract][Full Text] [Related]
9. Targeting the NLRP3 Inflammasome in Severe COVID-19.
Freeman TL; Swartz TH
Front Immunol; 2020; 11():1518. PubMed ID: 32655582
[TBL] [Abstract][Full Text] [Related]
10. Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.
Romacho T; Valencia I; Ramos-González M; Vallejo S; López-Esteban M; Lorenzo O; Cannata P; Romero A; San Hipólito-Luengo A; Gómez-Cerezo JF; Peiró C; Sánchez-Ferrer CF
Sci Rep; 2020 Mar; 10(1):5386. PubMed ID: 32214150
[TBL] [Abstract][Full Text] [Related]
11. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
13. NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis.
Luan J; Zhang X; Wang S; Li Y; Fan J; Chen W; Zai W; Wang S; Wang Y; Chen M; Meng G; Ju D
Front Immunol; 2018; 9():758. PubMed ID: 29692782
[TBL] [Abstract][Full Text] [Related]
14. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
Front Immunol; 2021; 12():741839. PubMed ID: 34512673
[TBL] [Abstract][Full Text] [Related]
15. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
[TBL] [Abstract][Full Text] [Related]
16. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
[TBL] [Abstract][Full Text] [Related]
17. The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages.
Duan Y; Wang J; Cai J; Kelley N; He Y
J Biol Chem; 2022 Dec; 298(12):102717. PubMed ID: 36403854
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitination and Activation of the NLRP3 Inflammasome by UCHL5 in HCV-Infected Cells.
Ramachandran A; Kumar B; Waris G; Everly D
Microbiol Spectr; 2021 Sep; 9(1):e0075521. PubMed ID: 34431717
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.
Primiano MJ; Lefker BA; Bowman MR; Bree AG; Hubeau C; Bonin PD; Mangan M; Dower K; Monks BG; Cushing L; Wang S; Guzova J; Jiao A; Lin LL; Latz E; Hepworth D; Hall JP
J Immunol; 2016 Sep; 197(6):2421-33. PubMed ID: 27521339
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis.
Povero D; Lazic M; McBride C; Ambrus-Aikelin G; Stansfield R; Johnson CD; Santini AM; Pranadinata RF; McGeough MD; Stafford JA; Hoffman HM; Feldstein AE; Veal JM; Bain G
J Pharmacol Exp Ther; 2023 Aug; 386(2):242-258. PubMed ID: 37308266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
